Skip Nav Destination
Letter|
January 30, 2023
Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes
Tariq Kewan,
Taussig Cancer Institute, Cleveland Clinic, United States
* Corresponding Author; email: tariqkewan@gmail.com
Search for other works by this author on:
Waled Bahaj,
Waled Bahaj
Cleveland Clinic Foundation, Cleveland, Missouri, United States
Search for other works by this author on:
Arda Durmaz,
Arda Durmaz
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, Ohio, United States
Search for other works by this author on:
Mai Mostafa Aly,
Mai Mostafa Aly
Cleveland Clinic, United States
Search for other works by this author on:
Olisaemeka D. Ogbue,
Olisaemeka D. Ogbue
Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
Search for other works by this author on:
Hetty E Carraway,
Hetty E Carraway
Cleveland Clinic, Cleveland, Ohio, United States
Search for other works by this author on:
Mikkael A. Sekeres,
Mikkael A. Sekeres
Sylvester Comprehensive Cancer Center, University of Miami, Miami, Ohio, United States
Search for other works by this author on:
Valeria Visconte,
Valeria Visconte
Cleveland Clinic, Cleveland, Ohio, United States
Search for other works by this author on:
Carmelo Gurnari,
Carmelo Gurnari
Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States
Search for other works by this author on:
Jaroslaw P. Maciejewski
Jaroslaw P. Maciejewski
Cleveland Clinic, Cleveland, Ohio, United States
Search for other works by this author on:
Blood blood.2022018896.
Article history
Submitted:
October 28, 2022
Revision Received:
January 12, 2023
Accepted:
January 17, 2023
Citation
Tariq Kewan, Waled Bahaj, Arda Durmaz, Mai Mostafa Aly, Olisaemeka D. Ogbue, Hetty E Carraway, Mikkael A. Sekeres, Valeria Visconte, Carmelo Gurnari, Jaroslaw P. Maciejewski; Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes. Blood 2023; blood.2022018896. doi: https://doi.org/10.1182/blood.2022018896
Download citation file:
Advertisement
Cited By
Email alerts
Advertisement
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal